HOME >> BIOLOGY >> NEWS
Mount Sinai Hospital researcher develops Canada's first embryonic stem cell lines

A senior scientist at Mount Sinai Hospital has developed Canada's first two human embryonic stem cell lines, giving researchers across the country new potential and hope for eventually discovering treatments and cures for many chronic and fatal diseases.

"My hope and the hope of my world-class laboratory team is that our step of developing the first Canadian embryonic stem cell lines will ultimately bring Canada and the world closer to treating or curing diseases such as Multiple Sclerosis, Parkinson's Disease, Alzheimer's Disease, Diabetes and spinal cord injuries," said Dr. Andras Nagy, a researcher at Mount Sinai's Samuel Lunenfeld Research Institute.

"Our research remains in an early phase but the ability of these cells to develop into any kind of function cells in adult bodies holds enormous promise for these cells to regenerate damaged tissues that cause incurable diseases."

The Canadian Institutes of Health Research's Stem Cell Oversight Committee (SCOC) determined that Dr. Nagy derived these new stem cells lines in a manner consistent with the Stem Cell Guidelines.

The two cell lines have since been submitted to, and approved by, the International Stem Cell Initiative (ISCI). The use of the two new lines in Canada will be directed by the Stem Cell Network. The McLaughlin Centre for Molecular Medicine at the University of Toronto contributes to the support of a human embryonic stem cell core facility.

The stem cell lines will be freely available to the Canadian scientific community and will enable Canadian scientists to research potential treatments for a variety of diseases.

"Having our own cell lines gives Canadian researchers access to a valuable research tool. These two lines will be shared with scientists all over Canada and with the scientific community at large. They are a valuable contribution to stem cell research on a global scale," said Dr. Michael Rudnicki, Scientific Director of the Stem Cel
'"/>

Contact: Rob McCartney
rmccartney@mtsinai.on.ca
416-586-3161
University of Toronto
8-Jun-2005


Page: 1 2

Related biology news :

1. Climate change isolates Rocky Mountain butterflies
2. Bernese Mountain Dogs prone to Borrelia burgdorferi infection
3. Bronfman gift to Mount Sinai catalyzes genomics-based medicine
4. NIH establishes Center of Excellence for influenza research at Mount Sinai
5. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
6. Sensational find: The mini-dinosaurs from the Harz Mountains
7. Brookhaven Lab and Mount Sinai form joint Center for Translational Biomedical Imaging
8. Mount Sinai School of Medicine and Bionostra Group collaborate to develop avian flu vaccine
9. University of Kentucky author captures national attention with Lost Mountain
10. Infectious disease expert warns of spread of Rocky Mountain spotted fever
11. Mount Sinai receives NIH funding for stem cell research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 22, 2020 , ... The field of quantitation of large molecules or ... dominated this area. However, the use of mass spectrometry in this field has gained ... question “How do you choose which approach to use (LBA or MS)?” In ...
(Date:6/19/2020)... ... ... Join experts from Envigo Lauren Klaskala, Project Manager – Custom Transgenic ... Wednesday, July 8, 2020 at 11am EDT (4pm BST/UK). , Nuclease-based technologies such as ... modifying the genome may be more straightforward, the challenge to create an optimal model ...
(Date:6/5/2020)... CULVER CITY, Calif. (PRWEB) , ... June 04, 2020 , ... ... is for the health and well-being of our attendees, staff, and the public. ... there are unique and safe ways to collaborate virtually,” said Julie Sutcliffe, President of ...
Breaking Biology News(10 mins):
(Date:7/7/2020)... ... , ... R3 International is now offering stem cell therapy for Alzheimers dementia ... on the patient's condition, treatment may be offered IV, intrathecal or with a combination. ... Alzheimers dementia, and the incidence continues to increase as individuals live longer. There is ...
(Date:7/1/2020)... , ... June 29, 2020 , ... ... to competitively procured purchasing contracts to its membership, recently named BioFit Engineered ... members with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and ...
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... ... are racing to develop a vaccine or drug treatment. In an effort to ... has publicly released the world’s largest imaging dataset portraying therapeutic compound effects ...
(Date:6/23/2020)... ... 23, 2020 , ... Kerafast Inc. , developers of ... the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, ... SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) ...
Breaking Biology Technology:
Cached News: